Science Explorer Interactive view Map
Topic · Surgery

Biomedical and Chemical Research

Biomedical and Chemical Research is a research topic within Surgery. Science Explorer counts 22k research works in it since 1950. 7.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers covers a wide range of topics in medical science and healthcare, including anaesthesia, clinical leadership, chemistry, neurology, physiology, cancer management, healthcare reform, and the use of medical gases. The papers discuss advancements in medical treatments, diagnostic techniques, and healthcare management.

  • Anaesthesia
  • Medical Gases
  • Clinical Leadership
  • Chemistry
  • Neurology
  • Physiology
  • Thermodynamics
  • Oxygen Consumption
  • Cancer Management
  • Healthcare Reform
Research works
22k
fractional, since 1950
In the world top 10%
1.5k
per year above
Top-10% rate
7.0%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
-1%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Biomedical and Chemical Research research?

By volume, Germany and the United States publish the most (1.1k and 136 works in 2022–2025).

By volume, 2022–2025

  1. 1 Germany 1.1k works
  2. 2 United States 136 works
  3. 3 Austria 72 works
  4. 4 Switzerland 68 works
  5. 5 India 52 works
  6. 6 United Kingdom 28 works
  7. 7 Japan 22 works
  8. 8 China 20 works
  9. 9 France 17 works
  10. 10 Italy 17 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

Germany: 71.9%United States: 8.8%Austria: 4.7%Switzerland: 4.4%6 others listed: 10.2%72%largest
Germany1,104 · 71.9%United States136 · 8.8%Austria72 · 4.7%Switzerland68 · 4.4%6 others listed156 · 10.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Biomedical and Chemical Research research?

By volume in 2022–2025, Charité - Universitätsmedizin Berlin publishes the most Biomedical and Chemical Research research, followed by KRH Klinikum Nordstadt and Philipps University of Marburg.

Who are the leading researchers in Biomedical and Chemical Research?

The most-cited researchers publishing on Biomedical and Chemical Research include Thomas Hofmann and Trevor W. Robbins.

  1. 1 Thomas Hofmann Germany 3.5k citations
  2. 2 Trevor W. Robbins United Kingdom 3.1k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Biomedical and Chemical Research research done?

The largest centres of Biomedical and Chemical Research research in 2022–2025 are Berlin (Germany), Hanover (Germany), Munich (Germany) and Cologne (Germany). Among places with at least 20 works in it, it is an unusually large share of all research in Marburg and Hanover.

Largest cities, 2022–2025

  1. 1 Berlin Germany 134 works
  2. 2 Hanover Germany 84 works
  3. 3 Munich Germany 67 works
  4. 4 Cologne Germany 45 works
  5. 5 Marburg Germany 35 works
  6. 6 Münster Germany 35 works
  7. 7 Hamburg Germany 34 works
  8. 8 Vienna Austria 30 works
  9. 9 Bonn Germany 23 works
  10. 10 Regensburg Germany 23 works

Where it is the local speciality

  1. MarburgDE · 34.9 works82×
  2. HanoverDE · 83.9 works66×
← less than its size predictsmore →

Location quotient: how much more of its research is in Biomedical and Chemical Research than the world average.

See Biomedical and Chemical Research on the map

Where is the best place to study Biomedical and Chemical Research?

Among universities, judged by research, University of Münster, Philipps University of Marburg and Ludwig-Maximilians-Universität München score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 4.08%fractional works in this node (log) →share in the world top 10% →University of Münster: 12, 25.2%Philipps University of Marburg: 34, 0.5%Ludwig-Maximilians-Universität München: 15, 4.0%Heidelberg University: 10, 2.4%Leibniz University Hannover: 8, 6.0%Hochschule Düsseldorf University of Applied Sciences: 9, 0.0%German Sport University Cologne: 11, 1.6%University of Cologne: 10, 0.2%Medizinische Hochschule Hannover: 10, 0.0%University of Regensburg: 12, 0.9%University of MünsterLudwig-Maximilians-U…Heidelberg UniversityPhilipps University …
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 University of MünsterGermany 72.125.2%21.2×12 +97.5%
2 Philipps University of MarburgGermany 44.30.5%87.6×34 -18.8%
3 Ludwig-Maximilians-Universität MünchenGermany 42.74.0%14.8×15 -43.6%
4 Heidelberg UniversityGermany 42.02.4%11.4×10 +22.4%
5 Leibniz University HannoverGermany 40.76.0%17.6×8 +6.5%
6 Hochschule Düsseldorf University of Applied SciencesGermany 39.50.0%128.3×9 +156.2%
7 German Sport University CologneGermany 36.81.6%111.4×11 0.0%
8 University of CologneGermany 36.10.2%19.5×10 -3.6%
9 Medizinische Hochschule HannoverGermany 35.20.0%30.2×10 +1.6%
10 University of RegensburgGermany 34.80.9%43.1×12 -68.0%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Biomedical and Chemical Research research growing?

Output in 2018–2022 was 1% lower than in 2013–2017, peaking in 2025. The fastest-growing topics are Biomedical and Chemical Research.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.